[
  {
    "uuid": "110b7cf8af1b650dc385348d9187d4f36e77113e",
    "url": "https://www.thehindu.com/sci-tech/health/has-semaglutide-transformed-treatment-of-diabetes-and-obesity-in-india/article68755461.ece",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "The Hindu Bureau",
    "published": "2024-11-07T22:00:00Z",
    "title": "Has semaglutide transformed treatment of diabetes and obesity in India? - The Hindu",
    "text": "A few years ago, one word began to do the rounds amongst people with diabetes and those struggling to lose weight: Ozempic . Touted as a wonder drug, it soon took the world by storm. Celebrities such as Elon Musk revealed that they had used it. Reports of “Ozempic parties” followed, and, as the drug’s popularity surged, supply became a drag in various countries.\nOzempic, known generically as semaglutide, is an injectable prescription drug. It was approved in 2017 by the United States Food and Drug Administration (FDA) for use in adults with type 2 diabetes. In 2021, the FDA approved of another injectable semaglutide, Wegovy, for chronic weight management in adults with obesity/overweight and with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol). Ozempic and Wegovy are manufactured by Danish drugmaker Novo Nordisk.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Health",
      "Science and Technology"
    ],
    "ai_allow": true,
    "canonical": false,
    "webz_reporter": false,
    "external_links": [
      "https://th-i.thgim.com/public/incoming/sf85nq/article66685524.ece/alternates/SQUARE_80/2023-03-29T220745Z_1067152215_RC2W30AOOHOJ_RTRMADP_3_USA-HEALTH.JPG",
      "https://www.linkedin.com/shareArticle?url=https%3A%2F%2Fwww.thehindu.com%2Fsci-tech%2Fhealth%2Fhas-semaglutide-transformed-treatment-of-diabetes-and-obesity-in-india%2Farticle68755461.ece&title=Has%20semaglutide%20transformed%20treatment%20of%20diabetes%20and%20obesity%20in%20India%3F%20",
      "https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.thehindu.com%2Fsci-tech%2Fhealth%2Fhas-semaglutide-transformed-treatment-of-diabetes-and-obesity-in-india%2Farticle68755461.ece&text=Has%20semaglutide%20transformed%20treatment%20of%20diabetes%20and%20obesity%20in%20India%3F%20",
      "https://t.me/share/url?url=https%3A%2F%2Fwww.thehindu.com%2Fsci-tech%2Fhealth%2Fhas-semaglutide-transformed-treatment-of-diabetes-and-obesity-in-india%2Farticle68755461.ece&text=Has%20semaglutide%20transformed%20treatment%20of%20diabetes%20and%20obesity%20in%20India%3F%20",
      "https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.thehindu.com%2Fsci-tech%2Fhealth%2Fhas-semaglutide-transformed-treatment-of-diabetes-and-obesity-in-india%2Farticle68755461.ece&t=Has%20semaglutide%20transformed%20treatment%20of%20diabetes%20and%20obesity%20in%20India%3F%20",
      "https://reddit.com/submit?url=https%3A%2F%2Fwww.thehindu.com%2Fsci-tech%2Fhealth%2Fhas-semaglutide-transformed-treatment-of-diabetes-and-obesity-in-india%2Farticle68755461.ece&title=Has%20semaglutide%20transformed%20treatment%20of%20diabetes%20and%20obesity%20in%20India%3F%20",
      "https://api.whatsapp.com//send?text=Has%20semaglutide%20transformed%20treatment%20of%20diabetes%20and%20obesity%20in%20India%3F%20%20-%20https%3A%2F%2Fwww.thehindu.com%2Fsci-tech%2Fhealth%2Fhas-semaglutide-transformed-treatment-of-diabetes-and-obesity-in-india%2Farticle68755461.ece",
      "https://reddit.com/submit",
      "https://t.me/share/url",
      "https://facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.thehindu.com%2Fsci-tech%2Fhealth%2Fhas-semaglutide-transformed-treatment-of-diabetes-and-obesity-in-india%2Farticle68755461.ece&t=Has%20semaglutide%20transformed%20treatment%20of%20diabetes%20and%20obesity%20in%20India%3F%20",
      "https://linkedin.com/shareArticle?url=https%3A%2F%2Fwww.thehindu.com%2Fsci-tech%2Fhealth%2Fhas-semaglutide-transformed-treatment-of-diabetes-and-obesity-in-india%2Farticle68755461.ece&title=Has%20semaglutide%20transformed%20treatment%20of%20diabetes%20and%20obesity%20in%20India%3F%20",
      "https://www.th-i.thgim.com/public/incoming/sf85nq/article66685524.ece/alternates/SQUARE_80/2023-03-29T220745Z_1067152215_RC2W30AOOHOJ_RTRMADP_3_USA-HEALTH.JPG",
      "https://www.api.whatsapp.com//send?text=Has%20semaglutide%20transformed%20treatment%20of%20diabetes%20and%20obesity%20in%20India%3F%20%20-%20https%3A%2F%2Fwww.thehindu.com%2Fsci-tech%2Fhealth%2Fhas-semaglutide-transformed-treatment-of-diabetes-and-obesity-in-india%2Farticle68755461.ece",
      "https://www.facebook.com/sharer/sharer.php",
      "https://www.linkedin.com/shareArticle",
      "https://www.reddit.com/submit?url=https%3A%2F%2Fwww.thehindu.com%2Fsci-tech%2Fhealth%2Fhas-semaglutide-transformed-treatment-of-diabetes-and-obesity-in-india%2Farticle68755461.ece&title=Has%20semaglutide%20transformed%20treatment%20of%20diabetes%20and%20obesity%20in%20India%3F%20",
      "https://www.t.me/share/url?url=https%3A%2F%2Fwww.thehindu.com%2Fsci-tech%2Fhealth%2Fhas-semaglutide-transformed-treatment-of-diabetes-and-obesity-in-india%2Farticle68755461.ece&text=Has%20semaglutide%20transformed%20treatment%20of%20diabetes%20and%20obesity%20in%20India%3F%20",
      "https://api.whatsapp.com//send",
      "https://www.twitter.com/intent/tweet?url=https%3A%2F%2Fwww.thehindu.com%2Fsci-tech%2Fhealth%2Fhas-semaglutide-transformed-treatment-of-diabetes-and-obesity-in-india%2Farticle68755461.ece&text=Has%20semaglutide%20transformed%20treatment%20of%20diabetes%20and%20obesity%20in%20India%3F%20",
      "https://twitter.com/intent/tweet"
    ],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [
        {
          "name": "United States Food and Drug Administration",
          "sentiment": "none"
        },
        {
          "name": "Novo Nordisk",
          "sentiment": "none"
        },
        {
          "name": "FDA",
          "sentiment": "none"
        }
      ],
      "locations": []
    },
    "syndication": {
      "syndicated": false,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "rating": null,
    "crawled": "2024-11-08T02:39:59.098+02:00",
    "updated": "2024-11-11T13:27:36.650+02:00"
  },
  {
    "uuid": "362667ee29efb00f23de4890e0f45ea31e08ef74",
    "url": "https://www.la-croix.com/taiwan-deux-morts-et-plus-de-500-blesses-apres-le-passage-du-typhon-kong-rey-20241101",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "AFP",
    "published": "2024-11-01T05:11:00Z",
    "title": "Taïwan: deux morts et plus de 500 blessés après le passage du typhon Kong-rey",
    "text": "Envoyer par mail Envoyer Partager sur Facebook Partager Partager sur Twitter Twitter Secouristes et services de nettoyage sont à l’oeuvre vendredi à Taïwan après le passage de Kong-rey, l’un des plus gros typhons que l’île ait connu ces dernières décennies et qui a fait au moins deux morts et plus de 500 blessés.\nLa tempête, accompagnée de bourrasques atteignant 184 km/h et de pluies torrentielles, a touché terre jeudi en début d’après-midi au sud-est du territoire, et a balayé l’île entière, arrachant des arbres, provoquant des inondations et des glissements de terrain.\nUn motard de 48 ans a été tué jeudi par la chute d’un poteau électrique à Taipei, et une femme de 56 ans est morte après la chute d’un arbre sur son véhicule, dans le comté de Nantou (centre), a déclaré l’agence nationale des incendies, tandis que plus de 500 autres personnes ont été blessées.\nUn motard à Keelung (nord), le 1er novembre 2024 / I-Hwa CHENG / AFP\nDes recherches sont en cours pour retrouver quatre personnes parties chasser dans les montagnes du centre de Taïwan mercredi et dont on est sans nouvelles.\nDeux randonneurs tchèques coincés dans le parc de Taroko du comté de Hualien pendant le typhon ont été secourus vendredi.\nEn traversant le détroit de Taïwan en direction de la Chine vendredi, Kong-rey s’est affaibli pour devenir une forte tempête tropicale, selon l’Administration météorologique centrale.\nDans tout Taïwan, le travail et les cours ont repris, et les magasins et les restaurants ont rouvert.\nCependant, près de 100.000 foyers sont toujours privés d’électricité et 191 vols intérieurs et internationaux ont été annulés.\nDes dizaines de liaisons ferrys et ferroviaires restent suspendues.\n« Le typhon était tellement fort » , rapporte Pan Li-chu, interrogé par l’AFP devant son restaurant à Taipei, où le store s’est plié avec la force du vent.\nConstater les dégâts\nWu Hsuan-kai constate les dégâts provoqués par le typhon Kong-Rey sur sa maison, à Yilan, le 1er novembre 2024 / I-Hwa CHENG / AFP\nDes pluies torrentielles se sont abattues sur la ville de Toucheng, dans la région d’Yilan, et ont fait couler de la boue et des débris dans les rues.\nLes inondations ont atteint le jardin de Wu Hsuan-Kai, 55 ans, qui regardait la télévision jeudi, quand il a entendu un étrange « grondement » .\n« Quand j’ai ouvert la porte, j’ai vu un coulée de boue arriver lentement, j’ai attrapé mes clefs de voiture et je suis parti en courant » raconte-t-il à l’AFP.\nDans la région de Taitung (sud-est) où le typhon s’est abattu en premier, les dégâts concernent « surtout des arbres qui sont tombés et se sont écrasés sur les poteaux électriques et provoqué des pannes de courant » , a expliqué un responsable des pompiers, qui n’a donné que son nom de famille, Huang.\nLevés aux aurores\nUne voiture écrasée par un arbre à Keelung (nord) le 1er novembre 2024 / I-Hwa CHENG / AFP\nDans toute l’île, des employés des services d’entretien se sont levés aux aurores afin de ramasser les arbres, les branches et autres débris sur les routes.\n« Nous avons commencé à nettoyer à partir de 5 heures du matin et nous n’avons nettoyé qu’un seul tronçon de route, cela nous a pris a peu près deux heures et demi » , a déclaré à l’AFP Lee Chia-hsin, un membre de l’équipe de nettoyage de la ville de New Taipei.\nTaïwan est habitué aux tempêtes tropicales, fréquentes de juillet à octobre, mais il est « inhabituel pour un typhon si puissant de frapper l’île aussi tard dans l’année » , note le météorologue Chang Chun-yao.\nLe changement climatique augmente leur intensité, avec de grandes averses, des crues soudaines et de très fortes rafales de vent, selon les scientifiques.\nKong-rey est le troisième typhon à frapper Taïwan depuis juillet.\nCet été, le typhon Gaemi a causé la mort de dix personnes et fait des centaines de blessés, provoquant de vastes inondations dans la ville méridionale de Kaohsiung.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "french",
    "sentiment": "negative",
    "categories": [
      "Weather",
      "Disaster and Accident",
      "Human Interest"
    ],
    "ai_allow": true,
    "canonical": false,
    "webz_reporter": false,
    "external_links": [
      "https://twitter.com/intent/tweet?&text=Taïwan:",
      "https://www.facebook.com/sharer/sharer.php?u=https://www.la-croix.com/taiwan-deux-morts-et-plus-de-500-blesses-apres-le-passage-du-typhon-kong-rey-20241101",
      "https://facebook.com/sharer/sharer.php?u=https://la-croix.com/taiwan-deux-morts-et-plus-de-500-blesses-apres-le-passage-du-typhon-kong-rey-20241101",
      "https://www.twitter.com/intent/tweet?&text=Taïwan:",
      "https://twitter.com/intent/tweet",
      "https://www.facebook.com/sharer/sharer.php"
    ],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "syndication": {
      "syndicated": null,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "rating": null,
    "crawled": "2024-11-01T07:22:10.029+02:00",
    "updated": "2024-11-01T07:22:10.029+02:00"
  },
  {
    "uuid": "b0b3c1f48e8cda2639a88284a9af7da594cc551b",
    "url": "https://www.noz.de/deutschland-welt/panorama/artikel/tunneleinsturz-in-los-angeles-31-arbeiter-gerettet-48967702",
    "ord_in_thread": 0,
    "author": "NOZ Medien",
    "published": "2025-07-10T07:34:00Z",
    "title": "Tunneleinsturz in Los Angeles: 31 Arbeiter gerettet",
    "text": "Schnelle Rettung Tunneleinsturz in Los Angeles: 31 Arbeiter gerettet\nVon\ndpa| 10.07.2025, 09:34 UhrDie Sorge ist zunächst groß, als erste Meldungen über einen Tunneleinsturz in Kalifornien bekannt wurden. Doch eine Katastrophe ist ausgeblieben.\nSie möchten weiterlesen?\nWählen Sie eine Option:\nSie sind bereits Digitalabonnent?\nAnmelden\nMonatsabo\n- Alle Artikel & Inhalte auf NOZ.de\n- News-App inkl. Push-Funktion\n- 1. Monat kostenlos, anschl. 14,95 € pro Monat\nProbemonat für 0 €\nMonatlich kündbar\nJahresabo (30 % sparen!)\n- Alle Artikel & Inhalte auf NOZ.de\n- News-App inkl. Push-Funktion\n14,95 €9,95 € pro Monat\nJetzt Angebot sichern\n12 Monate zum Vorteilspreis\nKommentarbereich laden\nAn dieser Stelle finden Sie den Kommentarbereich eines externen Anbieters.\nKommentarbereich laden\nMit Aktivierung der Checkbox erklären Sie sich damit einverstanden, dass Inhalte eines externen Anbieters geladen werden. Dabei können personenbezogene Daten an Drittanbieter übermittelt werden. Weitere Informationen finden Sie in unseren\nDatenschutzhinweisen",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "german",
    "sentiment": "positive",
    "categories": [
      "Disaster and Accident"
    ],
    "topics": [
      "Disaster and Accident->emergency response"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": null,
    "webz_reporter": false,
    "external_links": [],
    "entities": {
      "persons": [],
      "locations": [],
      "organizations": []
    },
    "syndication": {
      "syndicated": null,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": {
      "categories": [],
      "top_news": [
        "top_news_de",
        "top_news"
      ],
      "bias": null,
      "source": {
        "type": null,
        "city": null,
        "state": null,
        "country": null,
        "domain_type": null,
        "agency": null,
        "organization_name": null
      }
    },
    "rating": null,
    "crawled": "2025-07-10T12:45:20.578+03:00",
    "updated": "2025-07-11T10:10:14.000+00:00"
  },
  {
    "uuid": "90bd064910d82645518535759f66843fccdfc236",
    "url": "https://le10sport.com/football/ligue1/psg/mercato-le-psg-a-signe-le-meilleur-du-monde-729744",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Le10Sport.com",
    "published": "2025-01-23T22:00:00Z",
    "title": "Mercato : Le PSG a signé « le meilleur du monde»",
    "text": "Après la victoire de son équipe face à Manchester City en Ligue des champions ce mercredi, Nasser Al-Khelaïfi n'a pas tari d'éloges à l'égard de Luis Enrique. Considéré comme « le meilleur entraîneur du monde », le technicien espagnol est parti pour rester plusieurs années comme l'atteste sa signature au PSG jusqu'en juin 2027.\nLuis Enrique a gagné des points ce mercredi en l’emportant sur Manchester City dans un match décisif pour la qualification en Ligue des champions. Une victoire vécue aussi comme un soulagement chez Nasser Al-Khelaïfi, qui a tenu à remercier son entraîneur. « Je pense qu'on a le meilleur coach au monde » a confié le président du PSG. Une défaite n’aurait pas condamné Luis Enrique, qui vient tout juste de prolonger son contrat jusqu’en 2027.\nLuis Enrique soutenu par tous ! Une annonce choc pourrait bien arriver au PSG… Restez connectés ! ⚽️\n— le10sport (@le10sport)\n➡️[https://t.co/heYLDqo3y2][pic.twitter.com/2GQxUqz4FK][January 23, 2025]\nLuis Enrique a déjà signé !\n« Des nouvelles sur la prolongation de Luis Enrique ? Luis Enrique a prolongé son contrat jusqu'en 2027 comme Le Parisien l'avait révélé en octobre. Il est très heureux à Paris, le projet est fait pour lui, autour de lui, imaginé à partir de ses idées et de ses principes de jeu. Nasser Al-Khelaïfi l'adore. Luis Campos, qui sait que leurs destins sont liés, ne propose désormais que des joueurs qui correspondent au profil recherché par son coach » a confié Laurent Perrin, journaliste pour Le Parisien.\n« Il connaît trop ce milieu pour se projeter à très long terme »\nMais selon le journaliste, penser à un passage très longue durée de Luis Enrique est encore prématuré. « Luis Enrique est heureux mais il connaît trop ce milieu pour se projeter à très long terme. Il y a deux semaines, interrogé sur la possibilité de rester dix ans au PSG, il a répondu ceci : « J’espère, mais la réalité, c’est qu’il est très difficile de rester autant d’années dans un club de haut niveau. Quand on s’appuie sur la durée dans mes clubs précédents, je ne suis pas resté plus de quatre ans. J'ai eu besoin de me ressourcer, parce que l’énergie s’épuise » » a lâché Perrin.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "french",
    "sentiment": "positive",
    "categories": [
      "Sport",
      "Human Interest",
      "Lifestyle and Leisure"
    ],
    "topics": [
      "Sport->soccer",
      "Lifestyle and Leisure->game",
      "Lifestyle and Leisure->lifestyle"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": false,
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "syndication": {
      "syndicated": null,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": null,
    "rating": null,
    "crawled": "2025-01-24T00:15:10.501+02:00",
    "updated": "2025-01-24T00:15:10.501+02:00"
  },
  {
    "uuid": "bc2dba0ed796c8211d10a626605a92b60a514ac1",
    "url": "https://ph.investing.com/news/stock-market-news/sensei-biotherapeutics-advances-cancer-therapy-with-new-antibody-93CH-1192924",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Investing.com",
    "published": "2024-04-04T00:00:00Z",
    "title": "Sensei Biotherapeutics advances cancer therapy with new antibody By Investing.com",
    "text": "BOSTON - Sensei Biotherapeutics, Inc. (NASDAQ:SNSE), an immuno-oncology company, announced the publication of a paper in Nature Communications that details the development of a novel antibody, SNS-101, targeting a protein known to suppress immune response in cancer patients. The research, a collaboration with genOway and Washington University, St. Louis School of Medicine, presents a significant step in cancer immunotherapy, particularly addressing the challenges posed by the protein VISTA. VISTA, widely expressed on myeloid cells, was previously considered \"undruggable\" due to associated safety concerns and difficulty in achieving effective drug concentrations. SNS-101, a pH-sensitive monoclonal antibody, selectively binds to VISTA under acidic conditions typical of the tumor microenvironment, thereby avoiding the cytokine release syndrome (CRS) and pharmacokinetic issues seen with first-generation antibodies. The paper, titled \"VISTA checkpoint inhibition by pH-selective antibody SNS-101 with optimized safety and pharmacokinetic profiles enhances PD-1 response,\" demonstrates SNS-101's ability to activate T-cells by blocking VISTA's interaction with the PSGL-1 receptor, which could lead to fewer dose-limiting toxicities and off-target effects. Edward van der Horst, Ph.D., Chief Scientific Officer of Sensei Bio, expressed confidence in the antibody's design and its potential for clinical application, citing supportive initial data from ongoing Phase 1/2 studies. Sensei Biotherapeutics is focused on creating conditionally active therapeutics through its Tumor Microenvironment Activated biologics (TMAb™) platform. In addition to SNS-101, the company is developing other antibodies targeting different aspects of the tumor microenvironment, such as SNS-102, SNS-103, and SNS-201. The development of SNS-101 and its preclinical success are based on the company's research, which is part of their broader effort to offer new treatments for cancer patients. The company cautions that despite the promising nature of the research, there are inherent risks in the development of therapeutic candidates, including the possibility that the product candidates may not be successfully developed or commercialized. InvestingPro Insights As Sensei Biotherapeutics, Inc. (NASDAQ:SNSE) continues to make strides in the field of cancer immunotherapy with its novel antibody SNS-101, investors and industry observers are closely monitoring the company's financial health and market performance. According to InvestingPro, Sensei Biotherapeutics holds more cash than debt on its balance sheet, which is a positive sign for its financial stability. However, the company is quickly burning through cash and suffers from weak gross profit margins, which are important considerations for potential investors. The company's market capitalization stands at $23.82 million, and it has experienced a large price uptick over the last six months, with a 43.27% price total return. This growth could reflect investor optimism following the promising developments in the company's immunotherapy research. Sensei Biotherapeutics does not pay a dividend to shareholders, which is common for companies in the biotech sector focusing on reinvesting earnings into research and development. For those interested in a deeper analysis of Sensei Biotherapeutics, InvestingPro offers additional insights and metrics, including valuation implications and the company's profitability outlook. With a total of 9 additional [InvestingPro](/pro/pricing?referral=inv_in_article_anchor) Tips available for SNSE, investors can gain a comprehensive understanding of the company's potential and challenges. To access these insights and more, consider using the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription. Investors should note that the next earnings date for Sensei Biotherapeutics is set for May 7, 2024, which will provide further clarity on the company's financial trajectory and the progress of its therapeutic candidates like SNS-101. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Health"
    ],
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [
        {
          "name": "investing.com boston - sensei biotherapeutics, inc.",
          "sentiment": "neutral"
        },
        {
          "name": "st. louis school of medicine",
          "sentiment": "none"
        },
        {
          "name": "washington university",
          "sentiment": "none"
        }
      ],
      "locations": []
    },
    "rating": null,
    "crawled": "2024-04-05T00:44:38.416+03:00",
    "updated": "2024-04-05T00:44:38.416+03:00"
  },
  {
    "uuid": "4ab7cc594ff801123b4aabca346dd3d040f98098",
    "url": "https://flipboard.com/article/affordable-new-qi2-wireless-charger-lineup-keeps-gadgets-going/f-d3cc21b351%2Fcultofmac.com",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Cult of Mac - David Snow",
    "published": "2024-04-11T19:00:00Z",
    "title": "Affordable new Qi2 wireless charger lineup keeps gadgets going | Flipboard",
    "text": "Affordable new Qi2 wireless charger lineup keeps gadgets going Accessories brand ESR stocked a new collection of Qi2 chargers for iPhone and other devices this week on Amazon. It should help you charge at MagSafe speed levels, but ESR Qi2 wireless chargers come at lower prices than many MagSafe chargers. This post contains affiliate links. Cult of Mac may earn a … Related storyboards Related articles [I swapped my Apple Watch for a vintage Casio Chronograph – here are 8 surprising things I learned](/@techradar/techradar-the-full-screen-kdeniktpz/i-swapped-my-apple-watch-for-a-vintage-casio-chronograph-here-are-8-surprising/a-HhKMBltlS2eRqfUmQQLUug%3Aa%3A2416536031-0e162014d4%2Ftechradar.com) I live in Apple's world. I use an iPhone 15 Pro Max as my main smartphone, work on a lovely and fast MacBook Air 13-inch M3, occasionally work or … [Yale's newest smart locks won't even make you change your existing deadbolt](/@androidpolice/android-police-luihu8vvz/yale-s-newest-smart-locks-won-t-even-make-you-change-your-existing-deadbolt/a-AXbR8KTQT4m9xXfDh3AjMw%3Aa%3A1843397945-6833857729%2Fandroidpolice.com) Whether you live in an apartment or you’ve rented before, you are likely familiar with the downsides of living in a home you don’t own. In many … [Should you wait for AirPods Pro 3 or get AirPods Pro 2 now?](/@bgr/tech-c615n9ttz/should-you-wait-for-airpods-pro-3-or-get-airpods-pro-2-now/a-n7NuVqtsQQSnn5HNI_eKrA%3Aa%3A445942431-3f7cd32246%2Fbgr.com) Last we heard, Apple’s new AirPods Pro 3 aren’t expected to be released until sometime in 2025. Apple has reportedly been developing the new AirPods … Join the flipboard community Discover, collect, and share stories for all your interests [Sign up](/signup) More stories from [Consumer Tech](/topic/consumertechnology) [NO THANKS Samsung fans rage ‘it is awful now’ over huge smartphone change and blast ‘they realize they can charge us more’](/topic/consumertechnology/no-thanks-samsung-fans-rage-it-is-awful-now-over-huge-smartphone-change-and-bl/a-S0ObSElWQkqtpy1z_ewWKA%3Aa%3A2867092696-5cbe5f6112%2Fthe-sun.com) SOME Samsung users have been less than pleased with the lack of items that come with a new Galaxy device. In a recent Reddit post, one Samsung Galaxy … [The Onyx Boox Palma is the coolest gadget I’ve used in 2024](/topic/consumertechnology/the-onyx-boox-palma-is-the-coolest-gadget-i-ve-used-in-2024/a-hvsiNJACScaFVMRhJHdNXw%3Aa%3A201375877-10f42e2f39%2Fdigitaltrends.com) I recently checked my screen time for the month of March. It stood at just over two hours a day, less than half the time an average American spends … [Yale's newest smart locks won't even make you change your existing deadbolt](/topic/consumertechnology/yale-s-newest-smart-locks-won-t-even-make-you-change-your-existing-deadbolt/a-AXbR8KTQT4m9xXfDh3AjMw%3Aa%3A1843397945-6833857729%2Fandroidpolice.com) Whether you live in an apartment or you’ve rented before, you are likely familiar with the downsides of living in a home you don’t own. In many …",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
      "Science and Technology"
    ],
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [
        {
          "name": "esr",
          "sentiment": "negative"
        },
        {
          "name": "macbook air",
          "sentiment": "none"
        },
        {
          "name": "apple",
          "sentiment": "none"
        },
        {
          "name": "yale",
          "sentiment": "none"
        },
        {
          "name": "amazon",
          "sentiment": "none"
        },
        {
          "name": "casio chronograph",
          "sentiment": "none"
        }
      ],
      "locations": []
    },
    "rating": null,
    "crawled": "2024-04-12T00:09:12.716+03:00",
    "updated": "2024-04-12T00:09:12.716+03:00"
  },
  {
    "uuid": "b1784b994abc772e9a9c52d57d9fc2389bffd379",
    "url": "https://www.doctissimo.fr/beaute/soins-du-visage/voici-le-nouveau-geste-beaute-pour-une-hydratation-profonde-et-naturelle-322939.htm",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "Marie Lanen",
    "published": "2025-01-23T20:49:00Z",
    "title": "Voici le nouveau geste beauté pour une hydratation profonde et naturelle",
    "text": "Prendre soin de sa peau, c’est avant tout l’aimer. Pourtant, hydrater efficacement tout en respectant son équilibre reste un défi que nous sommes nombreux à relever au quotidien. C’est dans cette quête qu’intervient Neo by Nature, une marque française qui célèbre les actifs naturels puissants, avec sa nouvelle Crème Hydratante Activatrice.\nUne formule à la pointe de l’innovation\nAprès huit mois de recherche, Neo by Nature a mis au point une crème qui allie expertise scientifique et naturel. Avec 98% d’ingrédients d’origine naturelle, sa formule mise sur un trio d’actifs complémentaires :\n- L’acide hyaluronique, connu pour ses propriétés repulpantes et lissantes ;\n- L’algue brune, qui améliore la souplesse de la peau ;\n- L’aloe vera, un allié de choix pour apaiser et revitaliser.\nÀ voir aussi\nCes ingrédients, subtilement associés, garantissent une hydratation immédiate et durable sans effet collant. La peau est ainsi douce, souple et prête à affronter les agressions du quotidien.\nUne crème, trois actions essentielles\nHydrater, rééquilibrer et protéger : telles sont les promesses de la crème hydratante activatrice. Idéale pour toutes les peaux, cette innovation aide à restaurer l’éclat naturel du teint tout en renforçant la barrière cutanée.\nUne démarche 100 % française\nNeo by Nature s’appuie sur l’expertise d’un laboratoire breton pour élaborer cette formule, preuve d’un savoir-faire local et d’une exigence qualité élevée. En plus de son efficacité (93/100 sur Yuka), elle illustre l’engagement de la marque en faveur de produits à la fois respectueux et performants.\nUn rituel qui s’adapte à toutes les routines\nDisponible au prix de 19,90 €, cette crème hydratante constitue un geste simple mais essentiel à intégrer dans son quotidien. Une noisette suffit pour hydrater visage et cou, révélant une peau éclatante et prête à rayonner.\nEn offrant un soin expert à base d’actifs naturels, Neo by Nature transforme chaque application en un véritable moment de bien-être. Car après tout, une peau bien hydratée, c’est une peau que l’on aime encore plus.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "french",
    "sentiment": "positive",
    "categories": [
      "Lifestyle and Leisure",
      "Human Interest",
      "Social Issue"
    ],
    "topics": [
      "Lifestyle and Leisure->lifestyle",
      "Lifestyle and Leisure->wellness",
      "Social Issue->social services",
      "Social Issue->social condition",
      "Social Issue->values"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": false,
    "webz_reporter": false,
    "external_links": [],
    "external_images": [],
    "entities": {
      "persons": [],
      "organizations": [],
      "locations": []
    },
    "syndication": {
      "syndicated": null,
      "syndicate_id": null,
      "first_syndicated": false
    },
    "trust": null,
    "rating": null,
    "crawled": "2025-01-24T00:00:08.363+02:00",
    "updated": "2025-01-24T00:00:08.363+02:00"
  }
]
